3’,5’-Di-O-benzoyl thymidine
3’,5’-Di-O-benzoyl thymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
35898-30-7
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/3-5-di-o-benzoyl-thymidine.html
Solubility
10 mM in DMSO
Smiles
O=C(NC(C(C)=C1)=O)N1[C@@H]2O[C@H](COC(C3=CC=CC=C3)=O)[C@@H](OC(C4=CC=CC=C4)=O)C2
Molecular Formula
C24H22N2O7
Molecular Weight
450.44
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Ep-CAM / CD326 (VU-1D9), CF568 conjugate, 0.1mg/mL
C1QA / Complement C1q A-Chain (C1QA/2954), CF640R conjugate, 0.1mg/mL
Cytokeratin 8/18 (C-43 + DC10), CF640R conjugate, 0.1mg/mL
GP2 (Glycoprotein 2) / ZAP75 (GP2/2569R), CF488A conjugate, 0.1mg/mL
